Results 171 to 180 of about 3,288,372 (337)

Cytomegalovirus Infections in Patients Diagnosed with Inflammatory Bowel Disease. [PDF]

Infect Dis Clin Microbiol
İnan-Hekimoğlu M, Sarıcaoğlu EM, Çınar G, Akdemir İ, Gülten E, Törüner M, Ensari A, Savaş B, Memikoğlu KO.   +8 more
europepmc   +1 more source

Donor-derived cytomegalovirus-cytotoxic T lymphocytes and leflunomide successfully control refractory cytomegalovirus infections and disease of multiple sites after allogeneic-hematopoietic stem cell transplantation: A case report. [PDF]

Front Med (Lausanne), 2022
Su N, Liu Z, Sun P, Gu F, Yan X, Cai D.
europepmc   +1 more source

Cytomegalovirus infection after autologous bone marrow transplantation with comparison to infection after allogeneic bone marrow transplantation [PDF]

, 1988
John R. Wingard, Chen Dy, WH Burns, DJ Fuller, HG Braine, AM Yeager, Heather E. Kaiser, PJ Burke, ML Graham, GW Santos   +9 more
openalex   +1 more source

Virus-specific antibody activity of different subclasses of immunoglobulins G and A in cytomegalovirus infections

Infection and Immunity, 1983
G. Linde, L. Hammarström, M. Persson, C. I. Smith, V. Sundqvist, B. Wahren   +5 more
semanticscholar   +1 more source

Alemtuzumab Exposure and T Lymphocyte Depletion: A Population Pharmacokinetic‐Pharmacodynamic Model of Alemtuzumab Induction Therapy for Kidney Transplantation

Clinical Pharmacology &Therapeutics, EarlyView.
Alemtuzumab is a T cell‐depleting monoclonal antibody that is used for the prevention of kidney transplant rejection. The duration of lymphodepletion after the current standard induction therapy dose is likely longer than necessary, resulting in prolonged T cell lymphopenia with the associated risk of infections. Here, the interplay between alemtuzumab
Lukas K. van Vugt, Tom C. Zwart, Suzanne Bezstarosti, Sebastiaan Heidt, Marlies E. J. Reinders, Dennis A. Hesselink, Aiko P. J. de Vries, Brenda C. M. de Winter, Dirk Jan A. R. Moes   +8 more
wiley   +1 more source

Correction to: Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical Trial. [PDF]

Clin Infect Dis, 2023
europepmc   +1 more source

Cytomegalovirus infection. [PDF]

Archives of Disease in Childhood, 1971
openaire   +2 more sources

GatingTree: Pathfinding Analysis of Group‐Specific Effects in Cytometry Data

Cytometry Part A, EarlyView.
ABSTRACT Advancements in cytometry technologies have led to a remarkable increase in the number of markers that can be analyzed simultaneously, presenting significant challenges in data analysis. Traditional approaches, such as dimensional reduction techniques and computational clustering, although popular, often face reproducibility challenges due to ...
Masahiro Ono
wiley   +1 more source

Effect of sorafenib maintenance on Epstein-Barr virus and cytomegalovirus infections in patients with FLT3-ITD AML undergoing allogeneic hematopoietic stem cell transplantation: a secondary analysis of a randomized clinical trial. [PDF]

BMC Med, 2022
Xu X, Fan Z, Wang Y, Huang F, Xu Y, Sun J, Xu N, Deng L, Li X, Liang X, Luo X, Shi P, Liu H, Chen Y, Tu S, Huang X, Liu Q, Xuan L.   +17 more
europepmc   +1 more source

An Analysis of Cytomegalovirus Infection and HLA Antigen Matching on the Outcome of Renal Transplantation

, 1978
A G May, Robert F. Betts, Richard B. Freeman, Carl H. Andrus   +3 more
openalex   +2 more sources